Reset filters
  • 7 March 2013

New pro-drug tenofovir alafenamide appears equally effective but better tolerated

Read the article
Andrew Zolopa, Stamford University, presenting at CROI 2013. © Liz Highleyman / hivandhepatitis.com
  • 7 March 2013

Dosing of key TB drug rifampicin could go higher

Read the article
Martin Boeree, St Radboud University, Nijmegen, presenting at CROI 2013.
  • 6 March 2013

Continuing cotrimoxazole in children on ART reduces the risk of hospitalisation

Read the article
Mutsa Bwakura-Dangarembizi presenting at CROI 2013.
  • 6 March 2013

New NNRTI MK-1439 shows promise in early clinical trial

Read the article
Matt Anderson at CROI 2013. © Liz Highleyman / hivandhepatitis.com
  • 6 March 2013

Dual CCR5/CCR2 inhibitor cenicriviroc has anti-inflammatory as well as anti-HIV effect

Read the article
Joseph Gathe, Therapeutic Concepts, Houston, Texas © Liz Highleyman / hivandhepatitis.com
  • 6 March 2013

Small risk of neurological birth defects due to efavirenz confirmed in French cohort

Read the article
Jeanne Sibiude of Louis Mourier Hospital, France, presenting at CROI 2013.
  • 1 March 2013

In resource-rich countries, migrants have a higher risk of progressing to AIDS in the first year of HIV therapy

Read the article
  • 28 February 2013

Study shows value of hepatitis C therapy for HIV co-infected patients with compensated cirrhosis

Read the article
  • 26 February 2013

Meta-analysis shows superiority of integrase inhibitors in first-line HIV therapy and benefits for people changing treatment due to resistance

Read the article

Receive the latest HIV research and conference news

Complete this form to receive regular email bulletins including the latest HIV research and conference news from aidsmap and/or updates from Terrence Higgins Trust.

Get regular email bulletins

Please let us know how you'd like to be contacted by ticking the options below.